Skip to content

BeOne Medicines stock

ONCNASDAQ

BeOne Medicines AG, HealthcareISIN US07725L1026

$415.96▼ $4.02 (−1.0%)Closing price of 12 Nov 2026

70Score 70 out of 100, Strong

Turn on early warning

Price and trend

86 / 100

Price history

+10% in one year

The chart shows daily closes over 11 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 27% above it.

Trend change

Since August 2026 the 50-day line has been above the 200-day line; the trend has turned up.

Momentum

Normal: the price is neither overheated nor sold off (RSI 67).

Distance to the high

The price is 1.9% below its 52-week high. Largest decline in 11 years: 70% (September 2021 to May 2022).

Chart figures for advanced users
SMA 50$368.10
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$327.46
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)67
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$260.27
The lowest closing price of the last twelve months.
Resistance$424.00
The highest closing price of the last twelve months.
Market cap
$44.45B
Div. yield
no dividend
53.3
40.7
on earnings for the next twelve months ($10.23 per share)
Fair value
$271.42

Snapshot

Computed from the data by fixed rules, no AI

  • BeOne Medicines AG belongs to the Biotechnology industry (Switzerland) and, with a market value of $44.45B, is number 8 of 289 companies in its industry on MEQIRI.
  • American depositary receipt (ADR): 1 ADR = 13 shares.
  • MEQIRI Score 70 out of 100 (Strong): rank 142 of 702 in Healthcare, median 53.
Show more
  • The P/E is 53.3 (Biotechnology median 21.7, own median of recent years 115.5).
  • Our model puts fair value at $271.42, with the price 53% above it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Growing faster than its industryRevenue up 76.8% a year since 2020, Biotechnology median 19.4%.Growth 70
  • More cash than debtCash $5.78B, financial debt $1.15B.Stability 78
  • Analysts expect strong earnings growthUp 24.8% a year through 2028 (estimates from 12 analysts).Growth 70

Weaknesses

  • DilutionShare count up 31% since 2020.Capital allocation 54
70/ 100
MEQIRI Score
Strong

Its standout strengths are momentum and technical analysis, while valuation holds the score back.

Daily figure as of 13 Nov 2026

How the score is calculated

Score overview

The fundamentals are in the middle range.

Profit consistency10% of years
Cash conversion (free cash flow to earnings, 12 months)149%
ROIC (12 months)66.8%
Positive free cash flow10% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk medium

How well MEQIRI warns

In the middle among stocks ranked 101 to 1,000.

From 2016 to 2025, 13 in 100 such stocks fell 30% or more within a year, against a group average of 15 in 100.

What lowers it

  • price near its 52-week high

Valuation

Valuation signal

Modestly overvalued
Price
$415.96
Fair value
$271.42
Gap to fair value
+53%

In our model the price counts as cheap below $193.87 and expensive above $452.36 (uncertainty high, one part of the fair value is more than twice the other).

The two parts of the fair value come to $373.30 (cash-flow model) and $169.53 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.

Calculated with a cost of equity of 9%. At 10% the fair value would be $239.72, at 8% it would be $318.28.

Valuation metrics

2.59
30.9
Fair value (model)
$271.42
Earnings part $169.53 (earnings per share $7.81 × 21.7)

Half from the cash-flow model, half from earnings times the industry P/E (21.7).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

13 years

In the twelve months to 30 Sep 2026, revenue rose 32.9% on the twelve months before. Revenue has grown strongly since 2013, at around 67% per year.

Margins

13 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 87%, operating 8%, net 5%. Last 12 months: net 14%.

Debt & balance sheet

latest quarter
0.2
8.2x
3.55
Cash & equivalents
$5.78B

The balance sheet is solid, with low debt and comfortable interest coverage.

Earnings

Next earnings
25 Feb 2027in 104 days
Last reported
5 Nov 2026above expectations

Analyst estimates

Analysts have raised their 2026 earnings estimate by 16.5% since 15 Oct 2026.

Fiscal 202622 analysts
Earnings per share
8.48+16.5%
Revenue
$6.9B+1.8%
Fiscal 202722 analysts
Earnings per share
10.5+5.0%
Revenue
$7.94B+1.7%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook raised

Share price after the results: +2.1%

2026 guidance raised: revenue $6.6 billion to $6.8 billion (up $300 million), GAAP operating income $1 billion to $1.1 billion (up $250 million).

Supporting passage from the call, verbatim
“On the back of these strong results, we're raising our 2026 guidance ranges for revenue and GAAP operating income by $300 million and $250 million, respectively, and Aaron will detail this later.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 5 Aug 2026 (fiscal Q2 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases in the last 6 months. 11 insiders sold, $351.77M in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Ball Titus B.Sale

    6 Nov 2026, Principal Accounting Officer

    Shares
    19,929
    Price
    $31.20
    Value
    $621,712
  • Ball Titus B.Sale

    6 Nov 2026, Principal Accounting Officer

    Shares
    338
    Price
    $31.26
    Value
    $10,565
  • Lee Chan HenrySale

    5 Nov 2026, SVP, General Counsel

    Shares
    8,580
    Price
    $30.77
    Value
    $264,000
Show 163 more
  • Lee Chan HenrySale

    5 Nov 2026, SVP, General Counsel

    Shares
    5,915
    Price
    $30.92
    Value
    $182,910
  • Wang XiaodongSale

    27 Oct 2026, Board

    Shares
    11,440
    Price
    $27.35
    Value
    $312,892
  • Wang XiaodongSale

    27 Oct 2026, Board

    Shares
    18,720
    Price
    $27.36
    Value
    $512,087
  • Wang XiaodongSale

    27 Oct 2026, Board

    Shares
    16,107
    Price
    $27.50
    Value
    $442,990
  • Wang XiaodongSale

    27 Oct 2026, Board

    Shares
    21,853
    Price
    $27.60
    Value
    $603,052
  • Wang XiaodongSale

    27 Oct 2026, Board

    Shares
    16,640
    Price
    $27.67
    Value
    $460,444
  • Wang XiaodongSale

    27 Oct 2026, Board

    Shares
    4,160
    Price
    $27.74
    Value
    $115,404
  • Wang XiaodongSale

    27 Oct 2026, Board

    Shares
    30,303
    Price
    $27.87
    Value
    $844,639
  • Wang XiaodongSale

    27 Oct 2026, Board

    Shares
    105,924
    Price
    $27.94
    Value
    $2.96M
  • Wang XiaodongSale

    27 Oct 2026, Board

    Shares
    36,933
    Price
    $28.00
    Value
    $1.03M
  • Wang XiaodongSale

    27 Oct 2026, Board

    Shares
    51,545
    Price
    $28.11
    Value
    $1.45M
  • Wang XiaodongSale

    27 Oct 2026, Board

    Shares
    89,739
    Price
    $28.17
    Value
    $2.53M
  • Wang XiaodongSale

    13 Oct 2026, Board

    Shares
    93,171
    Price
    $26.89
    Value
    $2.51M
  • Wang XiaodongSale

    13 Oct 2026, Board

    Shares
    134,693
    Price
    $26.96
    Value
    $3.63M
  • Wang XiaodongSale

    13 Oct 2026, Board

    Shares
    73,853
    Price
    $27.03
    Value
    $2M
  • Wang XiaodongSale

    13 Oct 2026, Board

    Shares
    85,254
    Price
    $27.12
    Value
    $2.31M
  • Wang XiaodongSale

    13 Oct 2026, Board

    Shares
    16,380
    Price
    $27.17
    Value
    $445,078
  • Lee Chan HenrySale

    30 Sept 2026, SVP, General Counsel

    Shares
    14,495
    Price
    $28.85
    Value
    $418,125
  • Wang XiaodongSale

    28 Sept 2026, Board

    Shares
    2,080
    Price
    $27.46
    Value
    $57,115
  • Wang XiaodongSale

    28 Sept 2026, Board

    Shares
    1,560
    Price
    $27.59
    Value
    $43,045
  • Wang XiaodongSale

    28 Sept 2026, Board

    Shares
    520
    Price
    $27.63
    Value
    $14,366
  • Wang XiaodongSale

    28 Sept 2026, Board

    Shares
    29,133
    Price
    $27.77
    Value
    $809,120
  • Wang XiaodongSale

    28 Sept 2026, Board

    Shares
    55,107
    Price
    $27.86
    Value
    $1.54M
  • Wang XiaodongSale

    28 Sept 2026, Board

    Shares
    45,487
    Price
    $27.93
    Value
    $1.27M
  • Wang XiaodongSale

    28 Sept 2026, Board

    Shares
    44,447
    Price
    $28.01
    Value
    $1.24M
  • Wang XiaodongSale

    28 Sept 2026, Board

    Shares
    26,611
    Price
    $28.14
    Value
    $748,891
  • Wang XiaodongSale

    28 Sept 2026, Board

    Shares
    188,825
    Price
    $28.20
    Value
    $5.32M
  • Wang XiaodongSale

    28 Sept 2026, Board

    Shares
    9,594
    Price
    $28.25
    Value
    $271,012
  • Wang XiaodongSale

    8 Sept 2026, Board

    Shares
    97,396
    Price
    $26.79
    Value
    $2.61M
  • Wang XiaodongSale

    8 Sept 2026, Board

    Shares
    138,944
    Price
    $26.87
    Value
    $3.73M
  • Wang XiaodongSale

    8 Sept 2026, Board

    Shares
    85,397
    Price
    $26.94
    Value
    $2.3M
  • Wang XiaodongSale

    8 Sept 2026, Board

    Shares
    15,353
    Price
    $26.57
    Value
    $407,897
  • Wang XiaodongSale

    8 Sept 2026, Board

    Shares
    36,933
    Price
    $26.63
    Value
    $983,433
  • Wang XiaodongSale

    8 Sept 2026, Board

    Shares
    19,721
    Price
    $26.72
    Value
    $526,993
  • Wang XiaodongSale

    8 Sept 2026, Board

    Shares
    22,373
    Price
    $26.77
    Value
    $598,930
  • Wang XiaodongSale

    8 Sept 2026, Board

    Shares
    81,614
    Price
    $27.02
    Value
    $2.21M
  • Ball Titus B.Sale

    1 Sept 2026, Principal Accounting Officer

    Shares
    1,716
    Price
    $27.37
    Value
    $46,974
  • Wu XiaobinSale

    25 Aug 2026, President and COO

    Shares
    3,640
    Price
    $29.23
    Value
    $106,400
  • Oyler JohnSale

    12 Aug 2026, Chief Executive Officer

    Shares
    25,740
    Price
    $27.29
    Value
    $702,320
  • Oyler JohnSale

    12 Aug 2026, Chief Executive Officer

    Shares
    32,695
    Price
    $27.42
    Value
    $896,426
  • Oyler JohnSale

    12 Aug 2026, Chief Executive Officer

    Shares
    200,148
    Price
    $27.51
    Value
    $5.51M
  • Oyler JohnSale

    12 Aug 2026, Chief Executive Officer

    Shares
    271,687
    Price
    $27.57
    Value
    $7.49M
  • Oyler JohnSale

    12 Aug 2026, Chief Executive Officer

    Shares
    183,326
    Price
    $27.62
    Value
    $5.06M
  • Lee Chan HenrySale

    11 Aug 2026, SVP, General Counsel

    Shares
    34,658
    Price
    $27.69
    Value
    $959,760
  • Oyler JohnSale

    11 Aug 2026, Chief Executive Officer

    Shares
    178,035
    Price
    $27.64
    Value
    $4.92M
  • Oyler JohnSale

    11 Aug 2026, Chief Executive Officer

    Shares
    105,053
    Price
    $27.72
    Value
    $2.91M
  • Oyler JohnSale

    11 Aug 2026, Chief Executive Officer

    Shares
    189,397
    Price
    $27.81
    Value
    $5.27M
  • Oyler JohnSale

    11 Aug 2026, Chief Executive Officer

    Shares
    150,384
    Price
    $27.87
    Value
    $4.19M
  • Oyler JohnSale

    11 Aug 2026, Chief Executive Officer

    Shares
    174,239
    Price
    $27.96
    Value
    $4.87M
  • Oyler JohnSale

    11 Aug 2026, Chief Executive Officer

    Shares
    67,743
    Price
    $28.02
    Value
    $1.9M
  • Oyler JohnSale

    11 Aug 2026, Chief Executive Officer

    Shares
    41,288
    Price
    $28.10
    Value
    $1.16M
  • Oyler JohnSale

    11 Aug 2026, Chief Executive Officer

    Shares
    15,600
    Price
    $28.18
    Value
    $439,574
  • Oyler JohnSale

    11 Aug 2026, Chief Executive Officer

    Shares
    52
    Price
    $28.23
    Value
    $1,468
  • Oyler JohnSale

    10 Aug 2026, Chief Executive Officer

    Shares
    871
    Price
    $26.92
    Value
    $23,450
  • Oyler JohnSale

    10 Aug 2026, Chief Executive Officer

    Shares
    36,569
    Price
    $27.06
    Value
    $989,603
  • Oyler JohnSale

    10 Aug 2026, Chief Executive Officer

    Shares
    47,749
    Price
    $27.18
    Value
    $1.3M
  • Oyler JohnSale

    10 Aug 2026, Chief Executive Officer

    Shares
    87,321
    Price
    $27.29
    Value
    $2.38M
  • Oyler JohnSale

    10 Aug 2026, Chief Executive Officer

    Shares
    45,188
    Price
    $27.36
    Value
    $1.24M
  • Oyler JohnSale

    10 Aug 2026, Chief Executive Officer

    Shares
    161,434
    Price
    $27.43
    Value
    $4.43M
  • Oyler JohnSale

    10 Aug 2026, Chief Executive Officer

    Shares
    206,297
    Price
    $27.51
    Value
    $5.68M
  • Oyler JohnSale

    10 Aug 2026, Chief Executive Officer

    Shares
    585,572
    Price
    $27.59
    Value
    $16.16M
  • Oyler JohnSale

    10 Aug 2026, Chief Executive Officer

    Shares
    276,302
    Price
    $27.65
    Value
    $7.64M
  • Oyler JohnSale

    10 Aug 2026, Chief Executive Officer

    Shares
    47,840
    Price
    $27.74
    Value
    $1.33M
  • Rosenberg AaronSale

    3 Aug 2026, Chief Financial Officer

    Shares
    15,041
    Price
    $24.06
    Value
    $361,811
  • Lee Chan HenrySale

    30 Jul 2026, SVP, General Counsel

    Shares
    13,572
    Price
    $24.90
    Value
    $337,932
  • Lee Chan HenrySale

    22 Jul 2026, SVP, General Counsel

    Shares
    21,697
    Price
    $25.00
    Value
    $542,425
  • Oyler JohnSale

    21 Jul 2026, Chief Executive Officer

    Shares
    199,927
    Price
    $24.33
    Value
    $4.86M
  • Oyler JohnSale

    21 Jul 2026, Chief Executive Officer

    Shares
    260,377
    Price
    $24.38
    Value
    $6.35M
  • Oyler JohnSale

    21 Jul 2026, Chief Executive Officer

    Shares
    101,946
    Price
    $24.49
    Value
    $2.5M
  • Oyler JohnSale

    21 Jul 2026, Chief Executive Officer

    Shares
    205,491
    Price
    $24.56
    Value
    $5.05M
  • Oyler JohnSale

    21 Jul 2026, Chief Executive Officer

    Shares
    30,420
    Price
    $24.62
    Value
    $748,936
  • Oyler JohnSale

    20 Jul 2026, Chief Executive Officer

    Shares
    201,487
    Price
    $24.02
    Value
    $4.84M
  • Oyler JohnSale

    20 Jul 2026, Chief Executive Officer

    Shares
    66,898
    Price
    $23.85
    Value
    $1.6M
  • Oyler JohnSale

    20 Jul 2026, Chief Executive Officer

    Shares
    186,238
    Price
    $24.07
    Value
    $4.48M
  • Oyler JohnSale

    20 Jul 2026, Chief Executive Officer

    Shares
    81,549
    Price
    $23.90
    Value
    $1.95M
  • Oyler JohnSale

    20 Jul 2026, Chief Executive Officer

    Shares
    24,050
    Price
    $24.15
    Value
    $580,732
  • Oyler JohnSale

    20 Jul 2026, Chief Executive Officer

    Shares
    19,656
    Price
    $24.25
    Value
    $476,678
  • Oyler JohnSale

    20 Jul 2026, Chief Executive Officer

    Shares
    6,799
    Price
    $24.32
    Value
    $165,339
  • Oyler JohnSale

    20 Jul 2026, Chief Executive Officer

    Shares
    37,791
    Price
    $23.98
    Value
    $906,389
  • Oyler JohnSale

    20 Jul 2026, Chief Executive Officer

    Shares
    3,640
    Price
    $24.48
    Value
    $89,124
  • Oyler JohnSale

    17 Jul 2026, Chief Executive Officer

    Shares
    18,720
    Price
    $23.48
    Value
    $439,486
  • Oyler JohnSale

    17 Jul 2026, Chief Executive Officer

    Shares
    7,761
    Price
    $23.61
    Value
    $183,258
  • Oyler JohnSale

    17 Jul 2026, Chief Executive Officer

    Shares
    8,840
    Price
    $23.77
    Value
    $210,157
  • Oyler JohnSale

    17 Jul 2026, Chief Executive Officer

    Shares
    62,829
    Price
    $23.87
    Value
    $1.5M
  • Oyler JohnSale

    17 Jul 2026, Chief Executive Officer

    Shares
    72,059
    Price
    $23.96
    Value
    $1.73M
  • Oyler JohnSale

    17 Jul 2026, Chief Executive Officer

    Shares
    465,777
    Price
    $24.01
    Value
    $11.18M
  • Oyler JohnSale

    17 Jul 2026, Chief Executive Officer

    Shares
    193,895
    Price
    $24.09
    Value
    $4.67M
  • Oyler JohnSale

    17 Jul 2026, Chief Executive Officer

    Shares
    9,620
    Price
    $24.18
    Value
    $232,597
  • Oyler JohnSale

    17 Jul 2026, Chief Executive Officer

    Shares
    663
    Price
    $24.24
    Value
    $16,068
  • Oyler JohnSale

    16 Jul 2026, Chief Executive Officer

    Shares
    3,029
    Price
    $24.00
    Value
    $72,691
  • Oyler JohnSale

    16 Jul 2026, Chief Executive Officer

    Shares
    63,453
    Price
    $24.16
    Value
    $1.53M
  • Oyler JohnSale

    16 Jul 2026, Chief Executive Officer

    Shares
    123,708
    Price
    $24.21
    Value
    $2.99M
  • Oyler JohnSale

    16 Jul 2026, Chief Executive Officer

    Shares
    256,776
    Price
    $24.31
    Value
    $6.24M
  • Oyler JohnSale

    16 Jul 2026, Chief Executive Officer

    Shares
    418,912
    Price
    $24.37
    Value
    $10.21M
  • Oyler JohnSale

    16 Jul 2026, Chief Executive Officer

    Shares
    556,374
    Price
    $24.45
    Value
    $13.6M
  • Oyler JohnSale

    16 Jul 2026, Chief Executive Officer

    Shares
    83,226
    Price
    $24.50
    Value
    $2.04M
  • Oyler JohnSale

    16 Jul 2026, Chief Executive Officer

    Shares
    196,261
    Price
    $24.61
    Value
    $4.83M
  • Oyler JohnSale

    16 Jul 2026, Chief Executive Officer

    Shares
    266,565
    Price
    $24.69
    Value
    $6.58M
  • Oyler JohnSale

    16 Jul 2026, Chief Executive Officer

    Shares
    170,417
    Price
    $24.74
    Value
    $4.22M
  • Oyler JohnSale

    16 Jul 2026, Chief Executive Officer

    Shares
    20,280
    Price
    $24.82
    Value
    $503,424
  • Oyler JohnSale

    16 Jul 2026, Chief Executive Officer

    Shares
    6,760
    Price
    $24.89
    Value
    $168,265
  • Oyler JohnSale

    15 Jul 2026, Chief Executive Officer

    Shares
    78,871
    Price
    $23.85
    Value
    $1.88M
  • Oyler JohnSale

    15 Jul 2026, Chief Executive Officer

    Shares
    537,368
    Price
    $23.92
    Value
    $12.85M
  • Oyler JohnSale

    15 Jul 2026, Chief Executive Officer

    Shares
    167,141
    Price
    $23.98
    Value
    $4.01M
  • Oyler JohnSale

    15 Jul 2026, Chief Executive Officer

    Shares
    632,541
    Price
    $24.07
    Value
    $15.22M
  • Oyler JohnSale

    15 Jul 2026, Chief Executive Officer

    Shares
    99,320
    Price
    $24.12
    Value
    $2.4M
  • Oyler JohnSale

    14 Jul 2026, Chief Executive Officer

    Shares
    508,170
    Price
    $23.46
    Value
    $11.92M
  • Oyler JohnSale

    14 Jul 2026, Chief Executive Officer

    Shares
    596,635
    Price
    $23.55
    Value
    $14.05M
  • Oyler JohnSale

    14 Jul 2026, Chief Executive Officer

    Shares
    53,807
    Price
    $23.31
    Value
    $1.25M
  • Oyler JohnSale

    14 Jul 2026, Chief Executive Officer

    Shares
    530,153
    Price
    $23.61
    Value
    $12.52M
  • Oyler JohnSale

    14 Jul 2026, Chief Executive Officer

    Shares
    105,586
    Price
    $23.38
    Value
    $2.47M
  • Oyler JohnSale

    14 Jul 2026, Chief Executive Officer

    Shares
    101,842
    Price
    $23.66
    Value
    $2.41M
  • Oyler JohnSale

    13 Jul 2026, Chief Executive Officer

    Shares
    10,374
    Price
    $23.23
    Value
    $240,945
  • Oyler JohnSale

    13 Jul 2026, Chief Executive Officer

    Shares
    59,592
    Price
    $23.29
    Value
    $1.39M
  • Oyler JohnSale

    13 Jul 2026, Chief Executive Officer

    Shares
    341,822
    Price
    $23.37
    Value
    $7.99M
  • Oyler JohnSale

    13 Jul 2026, Chief Executive Officer

    Shares
    109,694
    Price
    $23.44
    Value
    $2.57M
  • Oyler JohnSale

    13 Jul 2026, Chief Executive Officer

    Shares
    10,998
    Price
    $23.51
    Value
    $258,508
  • Oyler JohnSale

    13 Jul 2026, Chief Executive Officer

    Shares
    94,120
    Price
    $23.60
    Value
    $2.22M
  • Oyler JohnSale

    13 Jul 2026, Chief Executive Officer

    Shares
    4,160
    Price
    $23.65
    Value
    $98,370
  • Oyler JohnSale

    10 Jul 2026, Chief Executive Officer

    Shares
    19,409
    Price
    $22.77
    Value
    $442,028
  • Oyler JohnSale

    10 Jul 2026, Chief Executive Officer

    Shares
    17,082
    Price
    $22.86
    Value
    $390,561
  • Oyler JohnSale

    10 Jul 2026, Chief Executive Officer

    Shares
    39,962
    Price
    $22.95
    Value
    $917,133
  • Oyler JohnSale

    10 Jul 2026, Chief Executive Officer

    Shares
    66,859
    Price
    $23.00
    Value
    $1.54M
  • Oyler JohnSale

    10 Jul 2026, Chief Executive Officer

    Shares
    4,810
    Price
    $23.09
    Value
    $111,044
  • Oyler JohnSale

    10 Jul 2026, Chief Executive Officer

    Shares
    1,950
    Price
    $23.17
    Value
    $45,177
  • Oyler JohnSale

    10 Jul 2026, Chief Executive Officer

    Shares
    1,768
    Price
    $23.25
    Value
    $41,098
  • Oyler JohnSale

    10 Jul 2026, Chief Executive Officer

    Shares
    234
    Price
    $23.31
    Value
    $5,455
  • Lee Chan HenrySale

    8 Jul 2026, SVP, General Counsel

    Shares
    8,632
    Price
    $23.27
    Value
    $200,833
  • Wu XiaobinSale

    23 Jun 2026, President and COO

    Shares
    16,796
    Price
    $21.25
    Value
    $356,927
  • Oyler JohnSale

    23 Jun 2026, Chief Executive Officer

    Shares
    23,400
    Price
    $21.02
    Value
    $491,949
  • Oyler JohnSale

    23 Jun 2026, Chief Executive Officer

    Shares
    16,770
    Price
    $21.09
    Value
    $353,613
  • Oyler JohnSale

    23 Jun 2026, Chief Executive Officer

    Shares
    4,160
    Price
    $21.16
    Value
    $88,030
  • Wang LaiSale

    23 Jun 2026, President, Global Head of R&D

    Shares
    13,884
    Price
    $21.29
    Value
    $295,553
  • Wu XiaobinSale

    16 Jun 2026, President and COO

    Shares
    17,641
    Price
    $20.52
    Value
    $361,997
  • Oyler JohnSale

    16 Jun 2026, Chief Executive Officer

    Shares
    21,450
    Price
    $20.37
    Value
    $437,042
  • Oyler JohnSale

    16 Jun 2026, Chief Executive Officer

    Shares
    22,230
    Price
    $20.46
    Value
    $454,835
  • Oyler JohnSale

    16 Jun 2026, Chief Executive Officer

    Shares
    4,329
    Price
    $20.51
    Value
    $88,809
  • Lee Chan HenrySale

    16 Jun 2026, SVP, General Counsel

    Shares
    7,670
    Price
    $20.46
    Value
    $156,925
  • Wang LaiSale

    16 Jun 2026, President, Global Head of R&D

    Shares
    15,197
    Price
    $20.41
    Value
    $310,236
  • Ball Titus B.Sale

    11 Jun 2026, Principal Accounting Officer

    Shares
    637
    Price
    $19.72
    Value
    $12,563
  • Ball Titus B.Sale

    11 Jun 2026, Principal Accounting Officer

    Shares
    1,560
    Price
    $19.81
    Value
    $30,904
  • Wang LaiSale

    11 Jun 2026, President, Global Head of R&D

    Shares
    9,828
    Price
    $20.08
    Value
    $197,318
  • Rosenberg AaronSale

    11 Jun 2026, Chief Financial Officer

    Shares
    8,203
    Price
    $19.83
    Value
    $162,637
  • Wu XiaobinSale

    11 Jun 2026, President and COO

    Shares
    8,138
    Price
    $20.09
    Value
    $163,512
  • Lee Chan HenrySale

    11 Jun 2026, SVP, General Counsel

    Shares
    5,564
    Price
    $19.82
    Value
    $110,268
  • Oyler JohnSale

    11 Jun 2026, Chief Executive Officer

    Shares
    9,633
    Price
    $19.71
    Value
    $189,865
  • Oyler JohnSale

    11 Jun 2026, Chief Executive Officer

    Shares
    11,167
    Price
    $19.81
    Value
    $221,271
  • Oyler JohnSale

    11 Jun 2026, Chief Executive Officer

    Shares
    2,600
    Price
    $19.87
    Value
    $51,656
  • Oyler JohnSale

    11 Jun 2026, Chief Executive Officer

    Shares
    1,937
    Price
    $19.91
    Value
    $38,563
  • Ball Titus B.Sale

    8 Jun 2026, Principal Accounting Officer

    Shares
    1,300
    Price
    $20.85
    Value
    $27,106
  • Ball Titus B.Sale

    8 Jun 2026, Principal Accounting Officer

    Shares
    468
    Price
    $20.93
    Value
    $9,795
  • Lee Chan HenrySale

    8 Jun 2026, SVP, General Counsel

    Shares
    9,243
    Price
    $20.79
    Value
    $192,138
  • Lee Chan HenrySale

    8 Jun 2026, SVP, General Counsel

    Shares
    2,080
    Price
    $20.87
    Value
    $43,401
  • Wang LaiSale

    8 Jun 2026, President, Global Head of R&D

    Shares
    17,251
    Price
    $20.72
    Value
    $357,418
  • Wang LaiSale

    8 Jun 2026, President, Global Head of R&D

    Shares
    520
    Price
    $20.83
    Value
    $10,829
  • Wu XiaobinSale

    8 Jun 2026, President and COO

    Shares
    18,772
    Price
    $20.72
    Value
    $388,916
  • Wu XiaobinSale

    8 Jun 2026, President and COO

    Shares
    520
    Price
    $20.81
    Value
    $10,822
  • Oyler JohnSale

    8 Jun 2026, Chief Executive Officer

    Shares
    49,660
    Price
    $20.80
    Value
    $1.03M
  • Oyler JohnSale

    8 Jun 2026, Chief Executive Officer

    Shares
    14,560
    Price
    $20.86
    Value
    $303,678
  • Riva AlessandroSale

    22 May 2026, Board

    Shares
    2,756
    Price
    $23.81
    Value
    $65,617
  • Dugan MargaretSale

    22 May 2026, Board

    Shares
    2,756
    Price
    $23.82
    Value
    $65,636
  • Sanders Corazon (Corsee) D.Sale

    22 May 2026, Board

    Shares
    2,756
    Price
    $23.81
    Value
    $65,633
  • Baker Bros. Advisors LpSale

    22 May 2026, Board

    Shares
    10,998
    Price
    $23.82
    Value
    $261,981

Shares and prices per ordinary share as filed with the SEC, not per depositary receipt (1 ADR = 13 shares). Filings per depositary receipt are converted to ordinary shares.

Partial trades from one filing are shown in one row, with the average price.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at BeOne Medicines

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

702 rated companies in Healthcare

Rank 142 of 702
142/ 702
This company
70
Sector median
53

Categories against the sector median

ProfitabilityMedian of 702 companies84 (median 38)46 above the median
GrowthMedian of 702 companies70 (median 54)16 above the median
FundamentalsMedian of 702 companies60 (median 46)14 above the median
ValuationMedian of 471 companies with a value25 (median 55)30 below the median
StabilityMedian of 702 companies78 (median 67)11 above the median
Capital allocationMedian of 702 companies54 (median 39)15 above the median
Technical analysisMedian of 702 companies86 (median 69)17 above the median
MomentumMedian of 702 companies88 (median 70)18 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Biotechnology

The next larger and next smaller companies by market value

All 289 Biotechnology stocks

ETFs that hold BeOne Medicines

Held by 2 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
L&G Pharma Breakthrough UCITS ETFETLI2.62%0.49%€26.29M
iShares Nasdaq US Biotechnology UCITS ETF2B700.91%0.35%€1.25B

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Strong since 8 Nov 2026, previously Neutral
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy